Showing results (471-480 of 977) with videos related to
Sort By:
Pageof 98
NPJ Breast Cancer|June 12, 2026
Real-world cell-free circulating tumor DNA (ctDNA) analysis identifies CDK4/6 inhibitor resistance and tumor evolution in HR+ advanced breast cancerS A Wander, C M Weipert, L Cabel, et al.NPJ Breast Cancer|May 28, 2026
Potential treatment targets in the whole-tissue proteome of triple negative breast cancerTram B Doan, Merridee A Wouters, Jiashu Hu, et al.NPJ Breast Cancer|May 29, 2026
Platinum-based neoadjuvant chemotherapy and the predictive role of DNA damage response biomarkers in TNBC: the NeoCarbo studyEriseld Krasniqi, Anna Di Benedetto, Lorena Filomeno, et al.NPJ Breast Cancer|June 12, 2026
Novel method for risk stratification of radiation-induced breast fibrosis: subgroup hypothesis verified by machine learningAhmad Sami, Petra Seibold, Carsten Sticht, et al.NPJ Breast Cancer|June 17, 2026
Exploiting androgen receptor agonism as a treatment strategy in estrogen receptor-positive metastatic breast cancerLaia Monserrat, Judith García-García, Cristina Molina, et al.NPJ Breast Cancer|June 30, 2026
Flavonoid-rich foods, genetic risk, and female breast cancer risk: a prospective cohort studyRui Yang, Yi-Lin Xu, Ying Wang, et al.NPJ Breast Cancer|July 1, 2026
Identifying the window of aggressive postpartum breast cancer based on the 21-gene Oncotype DX® test in women with HR+, HER2-negative breast cancerShiliang Zhang, Katelyn J Queen, Niharika Duggirala, et al.NPJ Breast Cancer|July 2, 2026
Stage-related transcriptional changes in HR-positive/HER2-negative breast cancerWilliam S O Symmans, Kevin Tran, Chunxiao Fu, et al.NPJ Breast Cancer|June 20, 2026
The suppressive function of ILC2 cells is regulated by β2-adrenergic receptor signaling in breast cancerJee Eun Choi, Qi Yan, Jianmin Wang, et al.NPJ Breast Cancer|June 24, 2026
Multimodal imaging and artificial intelligence for response assessment to neoadjuvant therapy in breast cancer: a comprehensive reviewLinlin Shao, Mingyu Zhang, Lili Zhang, et al.Pageof 98